Tonix Pharmaceuticals Holding Corp. (TNXP)

Focus On CNS Transforms During 2Q23


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
August 14, 2023
Report ID: 26049
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

Ticker
TNXP
Current Price
$0.1972 8.59%
Market Cap
$18.8M
Price Target
Refer to Report
Volume
7.0M
52wk Range
$0.1202 - $2.1253
Related Research Reports
4/11/2024

Increasing The Focus on Fibromyalgia
Increasing The Focus on Fibromyalgia (TNXP)
12/21/2023

Fibromyalgia Trial Meets All Endpoints
Fibromyalgia Trial Meets All Endpoints (TNXP)
9/6/2023

Long COVID Study Did Not Meet Primary Endpoint But Provides Important Data
Long COVID Study Did Not Meet Primary Endpoint But Provides Important Data (TNXP)
8/14/2023

Focus On CNS Transforms During 2Q23
Focus On CNS Transforms During 2Q23 (TNXP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy